Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
DAEWOONG CO., LTD. |
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 18,130 KRW | +4.50% | +8.56% | -10.91% | |
| Sales 2023 * | 1.82K 1.39 | Sales 2024 * | 1.88K 1.44 | Capitalization | 754B 577M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 0,55x |
| Net Debt 2023 * | 247.2 0.19 | Net Debt 2024 * | 198.6 0.15 | EV / Sales 2024 * | 0,51x |
| P/E ratio 2023 * | - | P/E ratio 2024 * | - | Employees | 347 |
| Yield 2023 * | 0,55% | Yield 2024 * | 0,55% | Free-Float | 33.11% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +4.50% | ||
| 1 week | +8.56% | ||
| Current month | +8.56% | ||
| 1 month | +13.45% | ||
| 3 months | +37.24% | ||
| 6 months | +22.01% | ||
| Current year | -10.91% |
1 week
16 550.00
18 450.00
1 month
15 030.0019 500.00
Current year
11 460.0022 150.00
1 year
11 460.0022 150.00
3 years
11 460.0086 700.00
5 years
6 470.0086 700.00
10 years
6 470.0086 700.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jae-Chun Yoon
CEO | Chief Executive Officer | 64 | 1985 |
Chang-Jae Lee
BRD | Director/Board Member | 46 | 2002 |
Woo-Bang Jeon
AUD | Comptroller/Controller/Auditor | 62 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Young-Cheol Kang
BRD | Director/Board Member | 67 | 2022 |
Jae-Chun Yoon
CEO | Chief Executive Officer | 64 | 1985 |
Geon-Haeng Lee
BRD | Director/Board Member | 62 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-07 | 18,130 | +4.50% | 292,745 |
| 23-12-06 | 17,350 | -1.42% | 102,165 |
| 23-12-05 | 17,600 | +1.56% | 161,701 |
| 23-12-04 | 17,330 | +3.90% | 125,081 |
| 23-12-01 | 16,680 | -0.12% | 112,508 |
End-of-day quote Korea Stock Exchange, December 06, 2023
More quotes
DAEWOONG CO., LTD. is a Korea-based holding company engaged in the management of its subsidiaries. The Company's subsidiaries include Daewoong pharmaceutical Co., Ltd and R&P Korea Co., Ltd, which are engaged in the manufacture of pharmaceuticals; Daewoong Life Science Co., Ltd., which is engaged in the food processing business; Daewoong Management Development Institute, which provides enterprise education solutions; IDS&TRUST Co., Ltd., which is engaged in the information technology (IT) solution business; Deawoong Bio Co., Ltd., which offers pharmaceutical raw materials, and Daewoong Development Co., Ltd., which is mainly engaged in the leasing of real estates, among other subsidiaries.
Sector
Pharmaceuticals
Calendar
2024-03-31
- Q4 2023 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
18,130KRW
Average target price
25,000KRW
Spread / Average Target
+37.89%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.91% | 549 M $ | |
| +23.76% | 35 711 M $ | |
| +29.50% | 21 213 M $ | |
| 0.00% | 13 068 M $ | |
| +13.65% | 11 676 M $ | |
| -17.24% | 8 754 M $ | |
| +56.67% | 7 718 M $ | |
| -0.05% | 6 788 M $ | |
| -0.73% | 5 005 M $ | |
| +48.74% | 4 817 M $ |
